Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
about
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Deeper molecular response is a ...... emia: the JALSG-STIM213 study.
@en
Deeper molecular response is a ...... emia: the JALSG-STIM213 study.
@nl
type
label
Deeper molecular response is a ...... emia: the JALSG-STIM213 study.
@en
Deeper molecular response is a ...... emia: the JALSG-STIM213 study.
@nl
prefLabel
Deeper molecular response is a ...... emia: the JALSG-STIM213 study.
@en
Deeper molecular response is a ...... emia: the JALSG-STIM213 study.
@nl
P2093
P2860
P1476
Deeper molecular response is a ...... kemia: the JALSG-STIM213 study
@en
P2093
Hideki Mitsui
Hiroshi Gomyo
Hitoshi Kiyoi
Hitoshi Suzushima
Itaru Matsumura
Japan Adult Leukemia Study Group
Katsumichi Fujimaki
Kazunori Ohnishi
Kazuto Togitani
Kensuke Usuki
P2860
P2888
P304
P356
10.1007/S12185-017-2334-X
P577
2017-09-19T00:00:00Z